Pages that link to "Q39643504"
Jump to navigation
Jump to search
The following pages link to A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations (Q39643504):
Displaying 12 items.
- Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitro (Q36693760) (← links)
- Cell-based in vitro models for predicting drug permeability (Q37994260) (← links)
- Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs). (Q38026512) (← links)
- The development of models for the evaluation of pulmonary drug disposition (Q38072075) (← links)
- Pharmaceutical applications of the Calu-3 lung epithelia cell line. (Q38111427) (← links)
- Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier (Q38785626) (← links)
- Drug Permeation Characterization of Inhaled Dry Powder Formulations in Air-Liquid Interfaced Cell Layer Using an Improved, Simple Apparatus for Dispersion (Q38826064) (← links)
- Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections (Q38859870) (← links)
- Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. (Q38946361) (← links)
- In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers (Q39022790) (← links)
- Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles (Q39421517) (← links)
- Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD. (Q47096485) (← links)